Real Before and After!
|
|
|
|
Consumer Information Center on Hair Loss, Hair Cloning, Hair Transplantation and Hair Loss Drugs |
|
|
|
| |
|
| Latest in Hair Cloning |
Latest on Hair Transplantation |
|
|
| Latest Additions to Photo Gallery |
|
|
Latest in Hair Loss News
|
Lexington International, LLC retains world renowned expert in laser phototherapy, Michael Hamblin, Ph.D, expanding its scientific advisory board - November 10, 2008
Lexington International, LLC, manufacturer and developer of the HairMax LaserComb® is pleased to welcome Dr. Michael Hamblin to its Scientific Advisory Board. Dr. Hamblin will provide professional expertise and guide Lexington in further understanding the biological mechanism of Photodynamic Therapy. In addition, Dr Hamblin will help Lexington model optimum energy parameters and assist in developing the most advanced and effective skincare devices for the consumer mass market.
Dr. Hamblin, a premier expert in the field of laser phototherapy, obtained his Ph.D. degree in 1977 from Nottingham Trent University in England. Dr. Hamblin is a principal investigator at Wellman Center of Photomedicine at Massachusetts General Hospital and an Associate Professor at Harvard Medical School. Dr. Hamblin's primary research interests cover applications of photodynamic therapy to cancer, infections and heart disease, and the use of low-level light therapy for wound healing, hair regrowth, inflammatory disorders, and brain damage. To date, Dr. Hamblin has authored or co-authored 86 peer-reviewed scientific research papers, filed over 12 U.S. patent applications, and given over 50 invited lectures in North America, Europe, and Asia. Dr. Hamblin chairs an annual conference at SPIE Photonics West BiOS meeting in San Jose, CA entitled "Mechanisms for Low Level Light Therapy".
Lexington is further expanding its home-use device market presence to include light phototherapy devices for skin care. The skin care device market is rapidly expanding and Lexington is poised to develop new skin care devices utilizing phototherapy technology. Lexington believes its key to success with these new skin care devices will be to develop, with Dr Hamblin's guidance, devices with optimal technical specifications and cutting-edge design both of which will ultimately provide positive user experiences.
Dr. Hamblin states, "We have demonstrated, in both clinical and laboratory settings, the benefits of photodynamic therapy (combination of non-toxic dyes and visible light), and photobiomodulation (stimulation of tissue by light alone). I believe light therapy has a great deal of utility to the general public, and I look forward to working with Lexington to provide advice on low level laser and other light therapy technology."
Co-founder and Managing Director of Lexington International, LLC, David Michaels said, "We are excited to have Dr. Hamblin, a key authoritative figure in the field of light therapy, available for advice and guidance to help Lexington maintain leadership in the low-level laser hair growth sector, and assist in our home use, skin care device development. The addition of Dr. Hamblin to our Medical Advisory Board reaffirms our commitment to continued research and contributions to the science behind light therapy devices for consumer use."
About the Medical Advisory Board
Lexington International has long been committed to facilitating positive user experiences, providing comprehensive customer support and business operation to the highest ethical standards. Lexington's Medical Advisory Board is a further extension of our dedication to quality. Each member represents a commitment to advancement of the hair care industry through ethical and credible practices, and is individually responsible for great contributions to the community. As a whole, the Medical Advisory Board can apply its expertise and credentials to support Lexington as we continue our efforts in providing a quality product to our customers. The Board consists of many established Key Authoritative Figures in the hair loss field who can attest first-hand to the efficacy of low level laser therapy in the treatment of Androgenetic Alopecia. In fact, these respected professionals have chosen to support our product based upon their experiences and belief that the HairMax LaserComb provides beneficial results.
For more information, please visit: HairMax website
|
|
|
Hair Loss News Archive
|
Lexington International, LLC retains world renowned expert in laser phototherapy, Michael Hamblin, Ph.D, expanding its scientific advisory board - November 10, 2008
HairMax Lasercomb is approved by Korean FDA - November 8, 2008
Chinese scientists developed new method of mass production of reconstituted dermal papillae that can be used as basis for hair cloning - November 7, 2008
British and German scientists discovered new gene variant which is strongly associated with male pattern baldness - October 10, 2008
Scientists developed new platform for large-scale production of dermal papilla microtissues for hair follicle regeneration - July 31, 2008
Scientists show that hair follicle stem cells can promote repair of spinal cord injury and recovery of walking function - July 30, 2008
Scientists at USC identify new mechanism that controls activation of hair stem cells - Jan 14, 2008
2007 year-end clinical trial update from Intercytex - Dec 30, 2007
Using human hair follicle bulge cells Chinese researches constructed skin suitable for wound repair - Dec 28, 2007
Researches found potent precursor cells of neuronal lineage in dermal papilla of adult hairs - Sep 27, 2007
News study reports that wounded adult skin can regenerate new hair follicles. - May 16, 2007
HairMax LaserComb receives FDA clearance - February 14, 2007
Upcoming European Hair Research Society 2006 Annual Meeting - June 12, 2006
Intercytex Ltd. performs first human phase I Study on Follicular Cell Implantation in Manchester, UK - June 12, 2006
Aderans institute report their progress on hair cloning - January 18, 2006
Loss of stem cells causes hair graying - March 14, 2005
Interview with Dr. Lu Zhongfa - January 19, 2005
Dr Gho's clinic has financial problems - December 28, 2004
Tooth cells can induce formation of new hairs - December 28, 2004
Surprising report on human hair cloning comes from China - November 25, 2004
Do hair stem cells form blood vessels? - October 21, 2004
Human follicular stem cells: their presence in plucked hair and follicular cell culture - June 2, 2004
Adult hair follicle stem cells can be used to clone new hairs - March 15, 2004
Hairier mouse with longer penis overexpressed gene-called Noggin - March 2, 2004
Sawaya on the *real* story behind hair loss research - March 2, 2004
Hair follicle dermal cells can form bone and fat tissue - January 15, 2004
New hairs from bone marrow - December 2, 2003
LG 70-2 - potential new hair growth stimulators - June 18, 2003
Highlights of Upcoming SID Meeting - April 20, 2003
CD34 - New marker for hair stem cells. New tool for gene therapy and tissue engineering - April 3, 2003
Regeneration of a new hair follicle from the upper half of a human hair - November 8, 2002
Hair dermal papillae and dermal sheath cells can give rise to blood stem cells - October 23, 2002
Dermal papilla gene expression profile - September 16, 2002
Cell proliferation and death in male pattern baldness - August 29, 2002
Highlights of 63rd Annual Meeting of Society of Investigative Dermatology - Part II - June 17, 2002
Highlights of 63rd Annual Meeting of Society of Investigative Dermatology - Part I - May 31, 2002
Pigment stem cells in hair follice - May 6, 2002
Skin epithelila cells can originate from hematopoietic stem cells - April 9, 2002
Opinion of experts - March 15, 2002
Stem cells are present in mouse hair follicle bulb - February 27, 2002
Inhibition of beta-cat/Lef1 pathway in skin - January 30, 2002
Cloned hairlines - bisection of hair follicles - January 30, 2002
|
|
|
|
|
|
|
| |
 |
. |
. |
|
|
|
|
|
